Pars Planitis: Understanding Chronic Eye Inflammation

The most frequently reported symptoms are floaters and blurred vision. Floaters appear as small spots, threads, or cobweb-shaped shapes that drift across the visual field. As inflammatory cells accumulate in the vitreous gel, vision may gradually take on a hazy quality. Notably, pars planitis typically does not cause eye pain, significant redness, or light sensitivity the way other forms of uveitis can. This quiet presentation can make it easy to dismiss early symptoms as minor, which is why prompt evaluation matters when new visual changes appear.

One of the most concerning features of pars planitis is that children may have no noticeable symptoms at all, even when significant inflammation is present. Young children often cannot recognize or articulate gradual changes in vision, which means the disease can go undetected for months or even years. Pars planitis accounts for a meaningful percentage of pediatric uveitis cases and is one of the more common serious inflammatory eye conditions seen in younger patients. Because children cannot always communicate what they are experiencing, routine eye exams and attentive observation by parents and caregivers are essential tools for early detection.

When pars planitis is left untreated or poorly controlled, it can lead to progressive vision loss. Without adequate treatment, a significant proportion of patients may experience meaningful vision decline over time. That decline may occur gradually through chronic retinal damage or more suddenly through complications such as vitreous hemorrhage (bleeding inside the eye). Pediatric patients tend to experience a more aggressive disease course than adults and face a higher risk of serious complications, which underscores the importance of early diagnosis and consistent care.

Many patients with pars planitis who receive consistent, appropriate care are able to maintain good functional vision over the long term. Research has found that a substantial majority of patients retain visual acuity of 20/40 or better after a decade of follow-up. However, pars planitis often follows a relapsing and remitting course, with periods of relative calm interrupted by flares of active inflammation. Long-term follow-up with a retina specialist remains important even during stable periods, because disease activity can return without warning.

Uncontrolled or inadequately treated pars planitis can lead to serious complications over time. The most common is cystoid macular edema (CME), a buildup of fluid and swelling in the central retina that can reduce central vision significantly. Other possible complications include:

• Cataract formation (clouding of the eye's natural lens)
• Glaucoma (elevated pressure inside the eye that can damage the optic nerve)
• Epiretinal membrane (a thin layer of scar-like tissue over the surface of the retina)
• Vitreous hemorrhage (bleeding into the vitreous gel)
• Retinal detachment (separation of the retina from the back wall of the eye)

Pediatric patients tend to face a higher risk of complications and a more aggressive overall disease course than adults, making consistent monitoring especially important in younger patients.

Because of the well-established association between pars planitis and multiple sclerosis, patients may be referred for neurological evaluation as part of their broader care. The risk of developing MS within several years of a pars planitis diagnosis is meaningful and appears to be higher in patients who present with periphlebitis (inflammation of retinal veins) at the time of their initial evaluation. Neurological assessment, which may include brain MRI, can help detect early signs of MS or rule it out. A retina specialist may coordinate this referral based on each patient's individual presentation and risk factors.

Yes, some patients achieve periods of remission where inflammation becomes inactive and vision remains stable, sometimes without active treatment. Remission does not mean the disease is permanently gone. Even during quiet periods, your retina specialist will continue monitoring for signs of recurrence, because inflammation can return without clear warning. The decision to taper or stop medication during remission is made gradually and carefully, based on how long the disease has been inactive, how well treatment worked previously, and how closely follow-up can be maintained going forward.

Pars planitis does not follow a straightforward hereditary pattern, meaning it is not directly passed from parent to child. However, certain HLA genetic markers associated with susceptibility can run in families, and the known link between pars planitis and multiple sclerosis means that a family history of MS or other autoimmune conditions may be relevant context for your retina specialist to know. If you have been diagnosed with pars planitis, it is reasonable to encourage family members who develop new visual symptoms to mention this family history when they visit their own eye care provider.

This distinction matters because it shapes how the condition is treated. Anterior uveitis (inflammation at the front of the eye) typically causes a red, painful, light-sensitive eye and is often managed with topical eye drops. Pars planitis, by contrast, usually causes no pain or redness and requires a different approach that more often involves periocular injections or systemic medications. The specific anatomical location of the inflammation, centered in the vitreous and peripheral retina, also accounts for the characteristic snowballs and snowbanks that are not seen in other subtypes of uveitis.

Treatment duration varies considerably from patient to patient. Some children achieve long-term remission after several years of well-controlled disease and are carefully transitioned off medication under close medical supervision. Others require ongoing or periodic therapy into adulthood, particularly when disease has been more aggressive or affects both eyes significantly. The most important practical guidance for parents is to maintain all scheduled follow-up visits and to discuss treatment progress honestly with your retina specialist at each appointment. Stopping medication independently, without specialist guidance, carries a real risk of allowing serious complications to develop quietly before they are caught.

This is a conversation worth having directly with your retina specialist. Whether neurological evaluation is recommended depends on your specific presentation, including whether periphlebitis (inflammation of retinal veins) was present at the time of diagnosis, which is associated with a higher risk of MS. If a referral to a neurologist is recommended, evaluation may include a brain MRI. Not every patient with pars planitis will develop MS, but awareness of the association means that any neurological symptoms such as numbness, coordination difficulties, or unexplained vision changes should be reported to your care team promptly rather than assumed to be unrelated to your eye condition.